Hikma's Advair Generic Gets Further Delayed Post author:Sam Post published:March 11, 2018 Post category:BioPharma Hikma Pharmaceuticals generic version of Advair has hit a stumbling block with the FDA. Source: BioSpace You Might Also Like Iovance Biotherapeutics Appoints As Chief Financial Officer August 8, 2017 Johnson & Johnson Employee Pleads With CEO, Lawmakers to Help Save DACA January 11, 2018 <b>Joe Ryan</b> Joins <b>BIT Group</b> As Vice President Business Development February 19, 2017
